When to boost
Sep 16, 2022
3 minutes
BY MICHAEL DAIGNAULT AND MONICA GANDHI
The View is reported by Eloise Barry, Mariah Espada, and Julia Zorthian
he promise of the mRNA vaccine technology platform was always that we could update shots quickly. With the approval by the FDA and CDC of bivalent vaccines, we may finally have an advantage over COVID-19: the updated vaccine recipe matches the current dominant circulating BA.4/BA.5 strains, with no other highly transmissible variant of concern yet on the horizon.
You’re reading a preview, subscribe to read more.
Start your free 30 days